ARCHIVES

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

Rogers Bill Would Authorize $937 Million For NCI In ‘78

March 4, 1977

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

DCBD To Fund Diagnostic Clinical Trials By CCOPs, Cooperative Groups

June 30, 1989

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

November 18, 1977

In Brief: Mueller, Rosenberg Head AACR; Elion, Schein Presidents Elect; PHS Offers epidemiology Training

May 7, 1982